Mind Cure stock is now much more easily accessible for U.S.-based investors.
Mind Cure stock is now much more easily accessible for U.S.-based investors.
Mind Cure Health just cashed up. Mind Cure's share price has recently slid. Buying opportunity.
Including its new financing, Mind Cure currently has in excess of CAD$5 million in cash.
Mind Cure's new CSO is a decorated researcher, entrepreneur and inventor.
Mind Cure's new Chief Science Officer (CSO) brings experience in drug research as well as natural product development.
Markets are tumbling. Where do you want to be positioned AFTER the selloff is over? Psychedelic stocks.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now